Washington Trust’s Quest Diagnostics DGX Stock Holding History

Washington Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,300	Closed	-$226K	–	286
2025 Q4	$226K	Sell	1,300 -334	-20%	-$60.8K	0.01%	264
2025 Q3	$311K	Buy	+1,634	New	+$290K	0.01%	238
2025 Q2	–	Sell	-323	Closed	-$54.7K	–	370
2025 Q1	$54.7K	Buy	323 +23	+8%	+$3.78K	﹤0.01%	393
2024 Q4	$45.3K	Hold	300	–	–	﹤0.01%	454
2024 Q3	$46.6K	Hold	300	–	–	﹤0.01%	463
2024 Q2	$41.1K	Sell	300 -60	-17%	-$8.22K	﹤0.01%	470
2024 Q1	$47.9K	Hold	360	–	–	﹤0.01%	458
2023 Q4	$49.6K	Hold	360	–	–	﹤0.01%	429
2023 Q3	$43.9K	Hold	360	–	–	﹤0.01%	412
2023 Q2	$50.6K	Hold	360	–	–	﹤0.01%	419
2023 Q1	$50.9K	Hold	360	–	–	﹤0.01%	410
2022 Q4	$56.3K	Hold	360	–	–	﹤0.01%	382
2022 Q3	$44K	Hold	360	–	–	﹤0.01%	410
2022 Q2	$48K	Hold	360	–	–	﹤0.01%	411
2022 Q1	$49K	Hold	360	–	–	﹤0.01%	435
2021 Q4	$62K	Hold	360	–	–	﹤0.01%	407
2021 Q3	$53K	Hold	360	–	–	﹤0.01%	507
2021 Q2	$48K	Buy	360 +60	+20%	+$7.86K	﹤0.01%	528
2021 Q1	$39K	Hold	300	–	–	﹤0.01%	552
2020 Q4	$36K	Hold	300	–	–	﹤0.01%	553
2020 Q3	$34K	Hold	300	–	–	﹤0.01%	515
2020 Q2	$33K	Hold	300	–	–	﹤0.01%	462
2020 Q1	$24K	Buy	+300	New	+$31.1K	﹤0.01%	516
2018 Q3	–	Sell	-1,013	Closed	-$111K	–	377
2018 Q2	$111K	Buy	+1,013	New	+$106K	0.01%	299

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Washington Trust's DGX Position: Q1 2026 in Review

Washington Trust sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,300 shares — an estimated $226K sold.

Washington Trust first reported a position in DGX in Q2 2018 and held it in 24 quarters. The position peaked at $311K in Q3 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Washington Trust reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Washington Trust sold 1,300 Quest Diagnostics shares in Q1 2026, an estimated $226K.
Washington Trust first reported a position in Quest Diagnostics in Q2 2018 and held it in 24 quarters.
Washington Trust's Quest Diagnostics position peaked at $311K in Q3 2025.
1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.